Adviser Investments LLC 9 Meters Biopharma, Inc. Transaction History

Adviser Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$0.21 - $0.32 $1,558 - $2,375	-7,422 Reduced 2.59%	278,826 $60,000
Q2 2022 Jul 14, 2022	BUY	$0.26 - $0.64 $14,393 - $35,430	55,360 Added 23.98%	286,248 $75,000
Q1 2022 May 04, 2022	BUY	$0.52 - $1.0 $86,805 - $166,933	166,933 Added 261.02%	230,888 $138,000
Q4 2021 Jan 31, 2022	BUY	$0.85 - $1.33 $54,361 - $85,060	63,955 New	63,955 $63,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Adviser Investments LLC with notifications on news.